Head, Developmental Therapeutics Clinic
Division of Cancer Treatment and Diagnosis, National Cancer Institute
Bethesda, Maryland, United States
Dr. Chen directs the Developmental Therapeutics Clinic (DTC) at the National Cancer Institute since 2014. Within the DTC, NCI facilitates the discovery and development of new anticancer drugs and drug targets, as well as piloting novel clinical trial designs that can be applied to the development of molecularly targeted agents on a national and international basis. Building on a collaboration with the Pediatric Oncology Branch, DTC, NCI has become a referral center for adult sarcoma patients. She led a trial of atezolizumab in Alveolar Soft Part Sarcoma that had led to approval of atezolizumab in this histology and first approval for pediatrics. This trial is reported in the NEJM. She is the director the Advance Developmental Therapeutic Training Program which trains medical oncologists in early phase drug development. Fellows in the program have won major awards including 2018 CTOS Young Investigator Award and 2020 ASCO Young Investigator awards. Dr. Chen is also the Chief Specialty Editor for the Frontiers Medicine: Precision Medicine. She has authored over 170 manuscripts and made presentations by invitation to major oncology meetings internationally on early phase clinical trials, precision medicine, DNA repair and CTCAE.
Disclosure information not submitted.
Thursday, November 2, 2023
9:00 AM – 10:00 AM
